Their inclusion does not guarantee they will be prescribed to any individual, as treatment decisions are ultimately at the discretion of healthcare providers
Compounded medications do not undergo FDA review for safety, effectiveness, or manufacturing quality
Just as combining different treatments is common for managing these conditions, it might seem logical to combine weight-loss medications for better results
Diabetes Care 41(2):356363 Karg MV, Bosch A, Kannenkeril D, Striepe K, Ott C, Schneider MP et al (2018) SGLT-2-inhibition with dapagliflozin reduces tissue sodium content: a randomised controlled trial
Also, a meta-regression analysis was conducted to evaluate the treatment duration and ALC daily dose as moderators in the HDRS and BDI datasets